176 related articles for article (PubMed ID: 35347892)
21. Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart.
McLarty JL; Marsh SA; Chatham JC
Life Sci; 2013 Mar; 92(11):621-7. PubMed ID: 22985933
[TBL] [Abstract][Full Text] [Related]
22. Elevated O-GlcNAcylation Promotes Malignant Phenotypes of Hypopharyngeal Squamous Cell Carcinoma by Stabilizing Nrf2 through Regulation of the PI3K/Akt Pathway.
Dai W; Jin X; Jiang B; Chen W; Ji Z; Xu X; Tang M; Dai K; Han L
Anticancer Agents Med Chem; 2020; 20(16):1933-1942. PubMed ID: 32538734
[TBL] [Abstract][Full Text] [Related]
23. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
[TBL] [Abstract][Full Text] [Related]
24. O-GlcNAcylation regulates β1,4-GlcNAc-branched N-glycan biosynthesis via the OGT/SLC35A3/GnT-IV axis.
Song W; Isaji T; Nakano M; Liang C; Fukuda T; Gu J
FASEB J; 2022 Feb; 36(2):e22149. PubMed ID: 34981577
[TBL] [Abstract][Full Text] [Related]
25. O-GlcNAcylation enhances anaplastic thyroid carcinoma malignancy.
Cheng YU; Li H; Li J; Li J; Gao Y; Liu B
Oncol Lett; 2016 Jul; 12(1):572-578. PubMed ID: 27347182
[TBL] [Abstract][Full Text] [Related]
26. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
27.
Zhang Z; Parker MP; Graw S; Novikova LV; Fedosyuk H; Fontes JD; Koestler DC; Peterson KR; Slawson C
J Biol Chem; 2019 Jan; 294(4):1363-1379. PubMed ID: 30523150
[TBL] [Abstract][Full Text] [Related]
28. O-GlcNAc modification, insulin signaling and diabetic complications.
Issad T; Masson E; Pagesy P
Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
[TBL] [Abstract][Full Text] [Related]
29. O-GlcNAcylation Negatively Regulates Cardiomyogenic Fate in Adult Mouse Cardiac Mesenchymal Stromal Cells.
Zafir A; Bradley JA; Long BW; Muthusamy S; Li Q; Hill BG; Wysoczynski M; Prabhu SD; Bhatnagar A; Bolli R; Jones SP
PLoS One; 2015; 10(11):e0142939. PubMed ID: 26565625
[TBL] [Abstract][Full Text] [Related]
30. Analytical and Biochemical Perspectives of Protein O-GlcNAcylation.
Ma J; Wu C; Hart GW
Chem Rev; 2021 Feb; 121(3):1513-1581. PubMed ID: 33416322
[TBL] [Abstract][Full Text] [Related]
31. Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation.
Oh YS; Heo K; Kim EK; Jang JH; Bae SS; Park JB; Kim YH; Song M; Kim SR; Ryu SH; Kim IH; Suh PG
Exp Mol Med; 2017 Jul; 49(7):e351. PubMed ID: 28684865
[TBL] [Abstract][Full Text] [Related]
32. Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.
Ma Z; Vosseller K
J Biol Chem; 2014 Dec; 289(50):34457-65. PubMed ID: 25336642
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms regulating O-linked N-acetylglucosamine (O-GlcNAc)-processing enzymes.
King DT; Males A; Davies GJ; Vocadlo DJ
Curr Opin Chem Biol; 2019 Dec; 53():131-144. PubMed ID: 31654859
[TBL] [Abstract][Full Text] [Related]
34. Quantitative time-resolved chemoproteomics reveals that stable
Qin W; Lv P; Fan X; Quan B; Zhu Y; Qin K; Chen Y; Wang C; Chen X
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6749-E6758. PubMed ID: 28760965
[No Abstract] [Full Text] [Related]
35. O-GlcNAcylation promotes migration and invasion in human ovarian cancer cells via the RhoA/ROCK/MLC pathway.
Niu Y; Xia Y; Wang J; Shi X
Mol Med Rep; 2017 Apr; 15(4):2083-2089. PubMed ID: 28259907
[TBL] [Abstract][Full Text] [Related]
36. Regulation of mitochondrial network homeostasis by O-GlcNAcylation.
Xue Q; Yan R; Ji S; Yu S
Mitochondrion; 2022 Jul; 65():45-55. PubMed ID: 35513218
[TBL] [Abstract][Full Text] [Related]
37. O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells.
Gu Y; Gao J; Han C; Zhang X; Liu H; Ma L; Sun X; Yu W
Mol Med Rep; 2014 Aug; 10(2):897-904. PubMed ID: 24865644
[TBL] [Abstract][Full Text] [Related]
38. TAZ mediates lysophosphatidic acid-induced migration and proliferation of epithelial ovarian cancer cells.
Jeong GO; Shin SH; Seo EJ; Kwon YW; Heo SC; Kim KH; Yoon MS; Suh DS; Kim JH
Cell Physiol Biochem; 2013; 32(2):253-63. PubMed ID: 23942151
[TBL] [Abstract][Full Text] [Related]
39. Hsp90 regulates O-linked β-N-acetylglucosamine transferase: a novel mechanism of modulation of protein O-linked β-N-acetylglucosamine modification in endothelial cells.
Zhang F; Snead CM; Catravas JD
Am J Physiol Cell Physiol; 2012 Jun; 302(12):C1786-96. PubMed ID: 22496241
[TBL] [Abstract][Full Text] [Related]
40. Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte.
Dehennaut V; Slomianny MC; Page A; Vercoutter-Edouart AS; Jessus C; Michalski JC; Vilain JP; Bodart JF; Lefebvre T
Mol Cell Proteomics; 2008 Nov; 7(11):2229-45. PubMed ID: 18617508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
